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LECTURE NOTES ????
1. Dyspepsia management
For primary care of un-investigated recent onset
dyspepsia, there are three main approaches:
1. Refer for upper endoscopy
2. Test for H. pylori with non-invasive tests and treat if
positive
3. Empirical treatment with prokinetics or proton-
pump inhibitors or H2-antagonists.
Many studies have been performed to look at the
results among these groups.
2. Gastric cancer
Incidence and mortality of gastric cancer in most parts
of Asia remain high.
1. There is definite link between H. pylori infection
and gastric cancer. Therefore H. pylori carriers are
at risk for gastric cancer.
2. If a subject has premalignant lesions (gastric
atrophy, intestinal metaplasia), the eradication of
H. pylori reverses the lesions in about 20-30% of
subjects only.
3. For subjects without premalignant lesions, there is
no data yet to answer whether eradication of H.
pylori will reduce the risk of gastric cancer in
future.
3. Helicobacter pylori infection
Prevalence
About half of the population in Hong Kong is infected
with Helicobacter pylori. Although H. pylori is associated
with a few GI and extra-GI diseases, majority of the
carriers will not have any disease manifestation
throughout their life.
LATEST DEVELOPMENT IN THE MANAGEMENT OF
ACID-RELATED DISEASES
16 October 2001 at Sheraton Hotel
Dr. Wong Chung Yu, Benjamin
M.B.,B.S.(H.K.), M.D.(H.K.), M.R.C.P.(U.K.), F.H.K.C.P., F.H.K.A.M.(Med.), F.A.C.G.
Associate Professor, Department of Medicine, The University of Hong Kong
Diagnosis
It is important to use appropriate tests for diagnosis of
H. pylori infection.
Invasive tests include:
1. Rapid urease test: including CLO test, home made
rapid urease test, PyloriTek test, and others. The
first two tests should be read at 24 hours, and the
third test can give a quicker diagnosis within one
hour.
2. Histology: Antral biopsy sample is needed.
3. Culture: Antral biopsy sample and special transport
medium are needed. This is the only test that
allows assessment of antibiotics sensitivity of the
organism.
4. PCR (polymerase chain reaction): Antral biopsy
sample is needed.
Non-invasive tests include:
1. Carbon-13 urea breath test (13C-UBT): Good for
both pre- and post-treatment diagnosis. Non-
radioactive, good for children and pregnant women.
Should be more widely used.
2. Stool antigen test: Easy to perform. Measures
antigen, not antibody. Need laboratory support.
3. Blood test — serology test. Based on antibody,
mostly ELISA based. Need laboratory support. Need
validation of accuracy in Hong Kong. Cannot be
used in post-treatment patient.
4. Blood test — whole blood. Based on antibody. Can
be performed in front of patient using one drop of
blood. Need validation of accuracy in Hong Kong.
Cannot be used in post-treatment patient.
5. Urine test. Based on antibody. Near patient test.
Need validation of accuracy in Hong Kong. Cannot
be used in post-treatment patient.
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Choice of tests:
1. Does the patient require an upper endoscopy?
2. First time test or post-treatment? If post-treatment,
wait for 4 weeks after stopping all drugs. Breath
test, histology and culture are best choices.
3. Blood test or any antibody test must NOT be used
for post-treatment.
4. Test results affected by recent (usually 2-4 weeks)
intake of proton-pump inhibitor, antibiotics, bismuth
compounds.
Treatment
It is important to confirm diagnosis before treatment.
It is also important to use the appropriate treatment
regime.
Treatment regime recommended by Asian Pacific
Consensus on Management of H.pylori.
1. Proton pump inhibitor (standard dose) +
clarithromycin 500 mg + amoxicillin 1 gm
2. Proton pump inhibitor (standard dose) +
clarithromycin 500 mg + metronidazole 400 mg
3. Ranitidine bismuth citrate (RBC) 400 mg +
clarithromycin 500 mg + amoxicillin 1 gm
4. Ranitidine bismuth citrate (RBC) 400 mg +
clarithromycin 500 mg +metronidazole 400 mg
ALL TWICE DAILY FOR 7 Days
If clarithromycin not available, switch to amoxicillin
and metronidazole. The eradication rate is around
10% lower than with clarithromycin.
Eradication rate affected by antibiotic resistance. In
Hong Kong, metronidazole resistance found in 49.4%
and clarithromycin resistance found in 10.8%. Dual
resistance found in 7%.
Other important points:
1. Non-ulcer dyspepsia — the symptom may not
respond to H.pylori eradication.
2. Symptoms recur after Hp eradication — look for
ulcer relapse, reinfection of Hp, Gastroesophageal
reflux disease (GERD), functional dyspepsia, or
irritable bowel syndrome.
3. Not all patients with pain or dyspepsia is due to Hp
infection.
4. Not all Hp carriers will benefit from Hp eradication.
